Modulators of cystic fibrosis transmembrane conductance regulator
US-2025340574-A1 · Nov 6, 2025 · US
This page is not indexed by search engines while we improve data quality.
Bridged systems
Bridged systems · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D515/08 |
| Official title | Bridged systems |
| Display label | Bridged systems |
| Total patents | 22 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is growing.
| Year | Patents |
|---|---|
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 4 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Cystic fibrosis transmembrane conductance regulator modulating agents
US-12421251-B2 · Sep 23, 2025 · US
Modulators of cystic fibrosis transmembrane conductance regulator
US-2024150377-A1 · May 9, 2024 · US
Enantioselective alkenylation of aldehydes
US-2024002400-A1 · Jan 4, 2024 · US
Modulators of cystic fibrosis transmembrane conductance regulator
US-2023416275-A1 · Dec 28, 2023 · US
Modulators of cystic fibrosis transmembrane conductance regulator
US-2023382924-A1 · Nov 30, 2023 · US
Modulators of cystic fibrosis transmembrane conductance regulator
US-2023382925-A1 · Nov 30, 2023 · US
Modulators of cystic fibrosis transmembrane conductance regulator
US-2023374038-A1 · Nov 23, 2023 · US
Cystic fibrosis transmembrane conductance regulator modulating agents
US-2022372047-A1 · Nov 24, 2022 · US
Tricyclic inhibitors of hepatitis b virus
US-2022110943-A1 · Apr 14, 2022 · US
Indazole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2
US-11104690-B2 · Aug 31, 2021 · US
Indazole derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2
US-2019330239-A1 · Oct 31, 2019 · US
Modified macrocyclic compounds
US-10214542-B2 · Feb 26, 2019 · US
Therapeutic compounds
US-10202360-B2 · Feb 12, 2019 · US
Transformation of meso-lactide
US-10174161-B2 · Jan 8, 2019 · US
Novel modified macrocyclic compounds
US-2018282346-A1 · Oct 4, 2018 · US
Oridonin analogs, compositions, and methods related thereto
US-10072022-B2 · Sep 11, 2018 · US
Transformations of meso-lactide
US-2018244841-A1 · Aug 30, 2018 · US
Oridonin analogs, compositions, and methods related thereto
US-2017313716-A1 · Nov 2, 2017 · US
Therapeutic compounds
US-2017298040-A1 · Oct 19, 2017 · US